XML 12 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Gain
Beginning balance at Dec. 31, 2024 $ 8,385 $ 6 $ 146,903 $ (138,526) $ 2
Beginning balance, shares at Dec. 31, 2024   60,800,130      
Issuance of common stock upon exercise of stock options 2   2    
Issuance of common stock upon exercise of stock options, shares   2,334      
Stock-based compensation expense 1,576   1,576    
Issuance of common stock in connection with the acquisition of fSight, shares   984,966      
Issuance of common stock in connection with the acquisition of fSight 815   815    
Issuance of common stock in connection with employee incentive restricted stock awards, shares   127,500      
Shares withheld for taxes upon restricted stock awards vesting, shares   (411)      
Unrealized gain (loss) resulting from change in fair value of marketable securities (2)       (2)
Net income (loss) (7,001)     (7,001)  
Ending balance, shares at Mar. 31, 2025   61,914,519      
Ending balance at Mar. 31, 2025 3,775 $ 6 149,296 (145,527) 0
Beginning balance at Dec. 31, 2024 8,385 $ 6 146,903 (138,526) 2
Beginning balance, shares at Dec. 31, 2024   60,800,130      
Net income (loss) (11,431)        
Ending balance, shares at Jun. 30, 2025   62,628,790      
Ending balance at Jun. 30, 2025 1,692 $ 6 151,646 (149,957) (3)
Beginning balance at Mar. 31, 2025 3,775 $ 6 149,296 (145,527) 0
Beginning balance, shares at Mar. 31, 2025   61,914,519      
Issuance of common stock upon exercise of stock options 95   95    
Issuance of common stock upon exercise of stock options, shares   160,019      
Stock-based compensation expense 2,300   2,300    
Issuance of common stock in connection with employee incentive restricted stock awards, shares   554,938      
Issuance of common stock in connection with at-the-market offering, net of offering costs, shares   2,243      
Issuance of common stock in connection with at-the-market offering, net of offering costs (42)   (42)    
Shares withheld for taxes upon restricted stock awards vesting (3)   (3)    
Shares withheld for taxes upon restricted stock awards vesting, shares   (2,929)      
Unrealized gain (loss) resulting from change in fair value of marketable securities (3)       (3)
Net income (loss) (4,430)     (4,430)  
Ending balance, shares at Jun. 30, 2025   62,628,790      
Ending balance at Jun. 30, 2025 1,692 $ 6 151,646 (149,957) $ (3)
Beginning balance at Dec. 31, 2025 27,623 $ 7 168,022 (140,406)  
Beginning balance, shares at Dec. 31, 2025   70,424,566      
Issuance of common stock upon exercise of stock options 103   103    
Issuance of common stock upon exercise of stock options, shares   235,359      
Stock-based compensation expense 1,608   1,608    
Issuance of common stock in connection with employee incentive restricted stock awards, shares   6,200      
Issuance of common stock in connection with employee incentive performance stock awards, shares   432,851      
Issuance of common stock in connection with registered direct offering, net of issuance costs, shares   5,000,000      
Issuance of common stock in connection with registered direct offering, net of issuance costs 14,042   14,042    
Shares withheld for taxes upon restricted and performance stock awards vesting, shares   (176,819)      
Shares withheld for taxes upon restricted and performance stock awards vesting (750)   (750)    
Shares withheld for taxes upon options exercised, shares   (62,329)      
Shares withheld for taxes upon options exercised (30)   (30)    
Net income (loss) (1,750)     (1,750)  
Ending balance, shares at Mar. 31, 2026   75,859,828      
Ending balance at Mar. 31, 2026 40,846 $ 7 182,995 (142,156)  
Beginning balance at Dec. 31, 2025 $ 27,623 $ 7 168,022 (140,406)  
Beginning balance, shares at Dec. 31, 2025   70,424,566      
Issuance of common stock upon exercise of stock options, shares 481,893        
Net income (loss) $ 424        
Ending balance, shares at Jun. 30, 2026   76,769,103      
Ending balance at Jun. 30, 2026 44,639 $ 7 184,614 (139,982)  
Beginning balance at Mar. 31, 2026 40,846 $ 7 182,995 (142,156)  
Beginning balance, shares at Mar. 31, 2026   75,859,828      
Issuance of common stock upon exercise of stock options 240   240    
Issuance of common stock upon exercise of stock options, shares   246,534      
Stock-based compensation expense 1,379   1,379    
Issuance of common stock in connection with employee incentive restricted stock awards, shares   662,741      
Net income (loss) 2,174     2,174  
Ending balance, shares at Jun. 30, 2026   76,769,103      
Ending balance at Jun. 30, 2026 $ 44,639 $ 7 $ 184,614 $ (139,982)